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ABSTRACT
Objective: Leave-on emollients form the mainstay of
eczema treatment, but adherence is poor. We aimed to
explore parents’/carers’ views on effectiveness and
acceptability of leave-on emollients for childhood
eczema through secondary analysis of data from 2
qualitative data sets.
Setting: Study 1 recruited through mail-out from 6
general practices in southern England. Study 2
recruited from a feasibility trial of an intervention to
support eczema self-care in 31 practices in the same
area.
Participants: Study 1 included 28 interviews with
carers of children aged ≤5 years with eczema. Study 2
included 26 interviews with carers of children aged
≤5 years with eczema.
Methods: Interviews followed semistructured guides:
study 1 explored carers’ understandings around
eczema treatments in order to develop a web-based
self-care support intervention; study 2 explored
carers’ understandings of eczema and eczema
treatments after using the intervention. Interviews
were carried out face to face or by telephone, audio-
recorded and transcribed. Secondary analysis of data
from both studies focused on views and experiences
of emollient use. Data were analysed using an
inductive thematic approach facilitated by NVivo V.10
software.
Results: In study 1, most participants felt
emollients improved eczema but held mixed views
about long-term use to prevent flare-ups. In study 2,
where carers had used the web-based intervention,
all participants held positive views about long-term
emollient use. In both studies, participants
expressed a range of preferences about emollient
‘thickness’; some felt that ‘thick’ emollients
(ointments) were most effective, while others found
these difficult to use. Carers described a process of
‘trial and error’, trying emollients suggested by
professionals, friends and family, or bought over-
the-counter. Carers expressed a need for
understanding differences between products and
their effective use.
Conclusions: Providing a rationale for long-term
emollient use and choice of emollients could help
improve adherence and help families gain more rapid
control of eczema.
BACKGROUND
Childhood atopic eczema, or atopic derma-
titis, is very common, affecting over 20% of
children aged ≤5 years at some point.1
Childhood eczema has signiﬁcant impact on
quality of life for children and their families,
particularly due to sleep disturbance and
itch.2 3 However, non-adherence to long-term
treatments for eczema is thought to be the
main barrier to effective treatment4 5 and
carers express frustrations with the advice
they receive.6–8
Guidelines suggest that emollients (non-
cosmetic moisturisers) form the mainstay of
treatment for eczema and should be used
regularly by all adults and children with
eczema, in addition to other treatments
(such as topical corticosteroids) for acute
ﬂare-ups and when in remission to prevent
ﬂare-ups.4 5
This article relates to leave-on, or directly
applied, emollients (as opposed to soap sub-
stitute or bath emollients). Leave-on emolli-
ents are thought to provide a protective layer
over the skin, decrease moisture loss and
occlude against irritants and are widely pre-
scribed at a cost of over £71 million per year
to the National Health Service in England.9
Consensus guidelines suggest that ointments
Strengths and limitations of this study
▪ This is one of the first qualitative studies to
explore parents’/carers’ views, experiences and
understandings of the use of leave-on emollients
for childhood eczema.
▪ A strength of this study is that it draws on two
study groups with different experiences of
eczema education and support, giving a diversity
of views and understandings.
▪ A limitation is that this is a secondary analysis: if
exploration of emollient use had been our
primary aim, we may have questioned partici-
pants about this in still greater depth.
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(thicker formulations such as white soft parafﬁn) can be
used when the skin is very dry and creams and lotions
when the skin is less dry.10 However, there is little evi-
dence regarding the relative effectiveness of different
emollients; guidelines conclude that prescribing should
be based on informed patient choice,11 or that, ‘The
correct emollient is the one that the child will use’.4 5
Qualitative studies have found that patients dislike con-
ventional treatments for eczema12 and are concerned
about a lack of information about treatments,6 although
existing research focuses mainly on topical corticoster-
oids.13 One qualitative study has included brief discus-
sion of emollient use, reporting that some participants
felt emollients provoked rather than prevented eczema
and some expressed disappointment at the limits of pro-
fessional knowledge and evidence base for the eczema
management, for instance stating that, ‘This “trial and
error” is a very primitive form of medicine’.8
In the quantitative literature, there is also more infor-
mation on topical corticosteroid use than emollient
use,14–18 although one study found that most carers of
children with eczema did not believe that emollients
prevented ﬂare-ups, even after receiving instruction
about this in secondary care.19
A recent feasibility trial20 and subsequent plans for a
full-scale trial have raised questions about carers’ views
of emollient use for childhood eczema. In light of the
paucity of data on this topic, we present unreported
ﬁndings from a secondary analysis of data collected as
part of two qualitative studies carried out among carers
of children with eczema. Study 1 was a qualitative inter-
view study with the primary aim of exploring views/
experiences around treatment for childhood eczema, in
order to inform the development of a web-based inter-
vention to support self-care. Study 2 was a qualitative
study among carers who had used the web-based inter-
vention, as part of its evaluation. We previously reported
ﬁndings from study 1 showing that some carers did not
believe emollients to be effective and that a minority
viewed emollients as ‘unnatural’ and potentially harmful
if used long term.7 We also previously reported that
carers described mixed feelings about the process of
‘trial and error’,7 a process that is often necessary to
ﬁnd an emollient that suits the child. These are
complex topics where carers held a wide range of views
and understandings. Here, we explore these in greater
depth and more fully describe and explore carers’ views
about the effectiveness, acceptability and choice of
leave-on emollients.
METHODS
The primary aim of study 1 was to explore carers’ views
and experiences of eczema treatments, in order to
develop a web-based intervention.7 21 22 Study 2 was
carried out among carers who had used the web-based
intervention, primarily as part of a process valuation and
to inform further reﬁnement of the intervention.23 Data
from both studies were reanalysed as the basis for this
article using an inductive thematic approach facilitated
by NVivo V.10 software.
Study 1
Population
Staff from six general practices in the south of England
searched their databases for children aged ≤5 years with
a recorded diagnosis of eczema and posted invitations to
‘parent or carer of [name of child]’. Carers were asked
to return a reply slip to the research team and, if they
were happy to participate and eczema was still a
problem, they were telephoned to arrange an interview.
Data collection
We purposively sampled participants with a range of par-
ental and child ages and differing geographical areas.
Informed consent was sought prior to the interviews,
which were semistructured and followed an interview
guide (box 1). Interviews lasted 30–60 min, taking place
in participants’ homes except for one where the partici-
pant chose to be interviewed at her health centre.
Interviews were carried out by MS, CH and HB from
December 2010 to May 2011. MS and HB are general
practitioners (GPs), but no participants were registered at
practices where they worked. CH was a medical student.
All introduced themselves as ‘researchers’. In a few cases
where participants asked after the researcher’s profes-
sional background or where participants had signiﬁcant
information needs, these were discussed after the end of
the interview. Interviews were audio-recorded, tran-
scribed and transcripts were checked against recordings.
Study 2
The interviews were carried out in the context of a feasi-
bility trial that randomised participants to three groups:
Box 1 Study 1 Interview guide
▸ Can you tell me a bit about your child’s eczema to start with?
– How does it affect your child?
– How does it affect family life?
– Can you tell me about what it was like when it first started?
– Can you tell me about how it has been more recently?
▸ Can you tell me about any professional advice you have had
about it?
▸ Can you tell me about any other kinds of advice or information
you have had? (other people? books, leaflets, internet?)
▸ What kinds of things do you do to try to cope with the
eczema?
– How do you feel about that?
– Can you tell me about any problems you have had with that?
▸ Do you do anything else to try and help your child’s eczema?
– Can you tell me about any difficulties you have doing these
things?
– If so, how do you get round these difficulties?
▸ How do other members of the family feel about the eczema?
▸ What else do you think would be helpful or would have been
helpful in the past?
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(1) web-based intervention plus usual care, (2) web-
based intervention plus healthcare professional support
plus usual care and (3) usual care alone. The web-based
intervention included information about rationale for
emollient use, videos on emollient use and a ‘2-week
challenge’ for carers to use emollients regularly and
judge the difference for themselves (box 2). Further
details are reported elsewhere.23
Population
We recruited to the feasibility trial via GP mail-out from
31 practices in the south of England using the same
methods as study 1, but with different practices. If carers
replied and the eczema was still a problem, they were
sent a unique login to complete online consent, ques-
tionnaire and randomisation and invited to provide
contact details if they were willing to participate in a
qualitative interview following participating in the feasi-
bility trial.
Data collection
We purposively sampled participants from lower socio-
economic class areas as these were less well represented
in study 1, while also seeking a range of ages and geo-
graphical areas. Semistructured interviews took place
at a location of participant’s choice: 15 in participants’
homes, 1 at the participant’s workplace and 10 by
phone. Interviews followed an interview guide (box 3)
and lasted 20–60 min. Interviews were carried out by MS
(GP) and HS (Medical Student) from November 2012
to February 2013, who introduced themselves as re-
searchers. Interviews were audio-recorded, transcribed
and transcripts were checked against recordings.
Data analysis
This secondary analysis focuses on the under-researched
topic of carers’ understandings of emollient use for
childhood eczema, particularly issues around effective-
ness, acceptability and choice of emollient.
In study 1 and study 2, all data relating to views or
experiences of emollients were assigned a broad overall
code (by MS and CH in study 1 and MS in study 2:
codes discussed with LY and IM). For the secondary ana-
lysis informing this article, all data relating to these
codes were retrieved for further subcoding (by MS in
discussion with IM), although data from the two studies
were kept separate in order to retain their different
contexts. Data were analysed using inductive thematic
analysis.24 Subcodes were developed into themes, sum-
maries written for each theme and counterexamples
were sought. Data saturation was achieved for the main
themes in studies 1 and 2, but the nature of this second-
ary analysis means that we did not check for saturation
of emollients codes during data collection. However, the
breadth and depth of data on emollients suggests it is
unlikely that further interviews would have yielded sub-
stantial new ﬁndings. NVivo V.10 software was used to
facilitate data handling. Pseudonyms have been assigned
in reporting the ﬁndings.
Box 2 Overview of web-based intervention in study 2
On their first visit to the website, users were offered two core
modules (‘What is eczema?’ and ‘Emollient moisturisers’) before
reaching a ‘menu’ of 14 modules, including diet and allergy,
topical corticosteroids, involving your child in treatment, bath-
time, sleep problems and managing scratching. On subsequent
visits to the website, users would go straight to the ‘menu’ of
modules.
The ‘2-week challenge’ was an optional component of the ‘emolli-
ent moisturisers’ module. Users were asked to sign up to using
emollients regularly for 2 weeks and were offered a ‘tick sheet’ to
help them with this (they were able to alter how many times per
day on the tick sheet). As part of the ‘2-week challenge’ they were
also offered daily SMS/text messages as reminders.
Some modules included short videos (∼4 min each) illustrating
techniques such as applying emollients or bathing a child. Links
to these videos were contained in the relevant modules, but there
were also links to all the videos in a button on the ‘menu’ screen.
Similarly, ‘print sheets’ (such as tick charts for children, action
plan to take to GP consultation, summary of eczema management
for relatives, school or nursery) appeared in the relevant modules,
but there were also links to all of these in a button on the ‘menu’
screen.
Box 3 Study 2 interview guide
▸ So can I ask, first of all, how did you find taking part in (study
of web-based intervention)?
▸ How did you feel about it overall? (How did it go overall?—
only if necessary)
▸ Has taking part in this changed how you feel about eczema?
– Has it changed how your family feels about the eczema?
– Has it changed anything for your child?
▸ Can you tell me a bit about how you used the website?
– How often did you use it?/Can you remember which sec-
tions you looked at?
– Did you do the 2-week challenge? How did that go?
– Was there anything that annoyed you about it, or any infor-
mation that you were hoping for and didn’t find?
▸ What had you been hoping to get from this study before
taking part?
NURSE GROUP ONLY
▸ Did you go and see the nurse to discuss the website?
If not, why not?
– If yes, how did it go overall?
– What did you discuss at this appointment?
– Did you find this appointment useful?
▸ Did it change how you feel about eczema, or how the eczema
is for your child?
NON-NURSE GROUP ONLY
How did you feel about not being offered an appointment with
the nurse?
EVERYONE
Is there anything that we haven’t discussed that you would like to
add?
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FINDINGS
We present ﬁndings on carers’ perceptions of whether
or not emollients work (for active eczema and to
prevent ﬂare-ups) and about which emollients are best,
including how carers reach decisions about this. We did
not speciﬁcally ask interviewees about emollients in
either study 1 or study 2, yet all interviewees mentioned
emollients when asked about their experiences of caring
for childhood eczema.
STUDY 1
Invitations were sent to 289 households. We received 70
replies, of which 33 said eczema was no longer a
problem, 3 declined for other reasons and 6 were not
contactable, resulting in 28 interviews (10% of mail-out)
(table 1). All participants in studies 1 and 2 were
parents of children with eczema, so we will present our
ﬁndings with reference to ‘parents’ rather than ‘carers’.
Do emollients help?
In study 1, we asked participants what treatments they
were using for their child’s eczema and their views and
experiences of using these. All interviewees mentioned
emollients. Most interviewees (21 of 28) said that they
thought the emollients did help their child’s eczema in
the short term, but that barriers to regular use meant
they did not always use them.
Caroline: If you forget, or we’re out, or I haven’t got the
cream with me or whatever, it’s worse the next day. If
he’s been away to his dad’s over the weekend and he’s
not done it, then I might need to use a bit of hydrocorti-
sone to get it back to that and then we just slap on
the Epaderm [ointment] again. It just goes on and on
and on.
Some parents described caution about applying emol-
lients to an infant or child, related to a feeling that
emollients are ‘unnatural’ or contain ‘chemicals’. Some
also expressed a view that the skin becomes ‘used to’
emollients and they lose their effectiveness if used
regularly.
Interviewer: You said earlier that you’d been reluctant to
use the creams, was that the steroid or all of them?
Hilary: Initially all of them. I had been trying just to
keep, you know, just natural products. The prospect of
putting on a cream that had 40 chemicals in then, just
didn’t sit well. But after trying an alternative for a short
period of time, I just thought, OK, well, this isn’t working
and I don’t have an option.
Interviewer: OK, and do you think the creams are
helping at the moment?
Sam: Sometimes I think they do and sometimes I think
they don’t. I think where I’m so used to it. Since I’ve
changed to the emulsiﬁer more than when I have done
the Epaderm, it works a bit—like I said—his body just
gets too used to it.
Some interviewees were less concerned about adverse
effects from emollients but were unconvinced about
their effectiveness, or about the rationale for continued
use of emollients, although most continued to use them.
Sabrina: The steroid certainly works, obviously because
they are quite a good one and they are very strong I think,
but other than that, I think the others—I’m not sure. I
know because it’s given by the GP or the dermatologist, so
there must be a reason why they give you cream like that
but it’s—it’s really just like a moisturiser, it doesn’t make it
better, it’s just to moisturise the skin, so basically, I’m not
sure whether they actually really, really work.
Two of the 31 interviewees felt that the emollient did
not work and did not use them. Leyla just felt that they
were ineffective, but Mandy felt that leave-on emollients
seemed to sting her daughter, so relied instead on bath
emollients and regular topical corticosteroids.
Mandy: She has this idea that her creams sting her legs
whereas the—I know the steroid cream doesn’t do that
because it’s obviously made to go on broken skin, but we
have put moisturiser on her and she’s cried and it’s been
all inﬂamed.
Table 1 Study 1 participant characteristics
Participant characteristics Description
Interviewee’s relationship to child* 27 mothers 4 fathers
Interviewee’s age Median 36 years (range 26–46 years)
Age of most affected child Median 3 years (range 7 months–5 years)
Severity (parent asked if child’s eczema
currently mild, moderate or severe)
16 mild 10 moderate 2 severe
Family structure Number of children in household median 2 (range 1–4); 27 households with
both parents, 1 household with mother only
Interviewees’ employment status* 14 full-time carers; 8 professional; 8 other such as admin or retail; 1 student
Ethnicity* 25 white British; 3 black or Asian British; 2 white non-British; 1 mixed
heritage British
*Total 31 interviewees from 28 families as 3 couples were interviewed together.
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Although most parents in study 1 said that they
thought regular emollients helped their child’s eczema,
there were more mixed views about the use of emollient
when the eczema was in remission. A few parents did
indeed feel that emollient helped prevent a ﬂare-up.
Interviewer: And what do you put on her skin at the
moment?
Pippa: We just use Unguentum [ointment] constantly,
cause I know if I stop using it, it goes really dry again and
then it’s prone to cracking and ﬂaring up.
More commonly, however, parents in study 1 described
using emollients only after symptoms of active eczema,
either because they seemed unaware of regular emolli-
ent use as a long-term treatment or because they ratio-
nalised that this was unnecessary. The following data
excerpt is typical:
Tina: I just don’t think it helps having constant moisture
on your skin… If it doesn’t need it, why put it on? Cos I
don’t put it on the rest of his body, it’s only where he
gets hot at night, he scratches and then I put it on him.
Which emollient is best?
Some people were aware of the different ‘thicknesses’
and types of emollient, particularly among parents with
longer experience of managing eczema. Interviewees
expressed a range of preferences for emollient type; for
some, ‘thickness’ seemed to be a barrier to adherence,
whereas for others, ‘thickness’ was essential to their view
that the emollient was effective and ‘greasiness’ was
something that they accepted:
Interviewer: Have there been any problems applying the
new cream?
Carrie: No, cause the cream she has is like—Diprobase
[cream], it’s like it is easier, is not too—cos the other
creams, we had a couple, I think it was Epaderm [oint-
ment], I’m not sure, but it was really thick, like Vaseline
[ointment], they were quite difﬁcult—they’re really thick,
greasy, really hard to apply, cos that ruined loads of
clothes, so you had to wash things. That was quite hard
work at the beginning, I’d say.
Rosie: I found it hard cause I couldn’t relieve any of the
symptoms. We didn’t have the Epaderm [ointment], we
had this Doublebase [gel] and it just didn’t seem to be
working: we were putting loads on her, it just seems to
make her greasy, I had to use the hydrocortisone [topical
corticosteroid] about, I don’t know 3 or 4 times a day
sometimes, because, you know her skin was ﬂaring up
that much and she seemed to scratch a lot more and
sometimes seemed to be in distress about it.
Many expressed confusion about the number of differ-
ent emollient products available and what the rationale
was behind choosing one over another. People were
keen to understand more about the different products
and sometimes seemed bewildered about why they were
prescribed particular emollients.
Interviewer: How many times do you think you’ve been
to [surgery] about it?
Helen: How many creams have I got? [laughter] [long
pause] Maybe 4… I think I saw a different person every
time. I know I deﬁnitely spoke to 2 different doctors and
2 different health visitors… One I was never recom-
mended by that practice, which all my friends seem to
get recommended is Diprobase [cream]. And actually
whether it probably was illegal but someone did actually
give me some to try, but I didn’t use it too much cos I
kind of thought, oh, it’s prescription and maybe they
haven’t given it to me for a reason. And I even men-
tioned it to one of the doctors, and they just said, well, I
tend to use this so he was never prescribed it. I don’t
really know why and why not.
‘Trial and error’
‘Trial and error’ is a term for the process of trying a
number of different emollients until one is found that
suits the child. Most interviewees seemed aware of ‘trial
and error’ and seemed comfortable with the concept
that different preparations might suit different children.
Interviewer: Where did you ﬁrst get advice from?
Sarah: I think quite a lot of it—trial and error on differ-
ent creams, so different GPs giving me different things,
giving me different advice, going back and asking differ-
ent things. But the Epaderm is what really seemed to get
on top of it and it was just trial and error to see actually
what I had to do.
‘Trial and error’ could be initiated by health profes-
sionals or by friends, family or parents themselves. In
many accounts, ‘trial and error’ had been initiated by
the family:
Carrie: I’ve only found out about different emollients
and things like that by investigating it myself; they sort of
gave me standard emollients that they prescribe, and it
didn’t really suit her skin very well… her skin just used to
be red after using it. And we changed it to the Balneum
which seems to be better, better for her. I’ve found that
on my own.
There were some parents who found the process of
‘trial and error’ from their healthcare provider a negative
experience and, as previously reported,7 linked this with
feeling that this was an insufﬁcient response from health
professionals and that they wished for something else.
Interviewer: OK, in what way do you think he could have
helped more?
Sam: Well he just gave me more creams, basically, I’ve
had creams since he was born; I’ve got loads of different
creams in the house, I could make a chemist, do you
know what you mean.
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FINDINGS FROM STUDY 2
Of the 143 people who took part in the pilot study, 82
agreed to be contacted for a feedback interview. We
approached 45 of these after they had completed
follow-up, of whom 14 were uncontactable, 4 declined to
be interviewed, 1 gave feedback by email and 26 were
interviewed (table 2).
Participants in study 2 were not directly asked about
their views of emollients, and yet emollient use arose in
response to a question about changes in their child’s
eczema since using the web-based intervention. Themes
relating to emollient use were broadly similar to study 1,
in particular reﬂections on whether emollients worked
and which were best, but participants in study 2 held
more positive views about regular emollient use to
prevent ﬂare-ups and the process of ‘trial and error’.
Do emollients help?
All participants in study 2 seemed convinced that emolli-
ents worked and many spoke about regular use of emol-
lients to prevent ﬂare-ups. Unlike in study 1, no
participants spoke about avoiding long-term use. Several
parents said that they had not really felt that emollients
helped until they used them more frequently and in
greater volumes, as a result of using the website. Nicole
mentioned that she had taken up the ‘2-week challenge’
section of the web-based intervention (box 2).
Interviewer: And how did it go [2 week challenge]?
Nicole: Brilliant. It just made me use moisturisers a lot
more. Before that I had just worked with the eczema
when there was a ﬂare up, mostly with the hydrocorti-
sone, but I didn’t do anything when the eczema wasn’t
there. It made me deal with it all the time and that has
made an absolute difference, deﬁnitely.
Several interviewees commented that their approach
to emollient use had altered through using the website.
For instance, the website included video demonstrations
of how to apply emollient, which were mentioned by
some.
Interviewer: Any more information that you’d like to
know about it?
David: Okay, so it was—it was about, it was literally about
trying different things; the main one was, for me, was
sheer quantity, but that was on there, because you saw it.
It was like, crikey, you’re putting a dirty great handful on,
where we were being quite sparing with it.
The website was designed as a behaviour change inter-
vention to increase emollient use and some parents
commented that establishing a ‘habit’ of regularly using
emollients had led them to observing more beneﬁt from
emollients than previously.
Interviewer: So you said that the regular text reminders
had made a bit of a difference (P: Yes) with doing the
Diprobase, did you see any difference in [youngest
child’s] eczema with that?
Annie: Yes, yes, it did—it did—it did start to clear,
although it certainly—it was really, really super dry. Yes,
doing it every day deﬁnitely, yes, I should do it every day
anyway, if I was a good mother I would. [laughter] But
the text [SMS reminder], it was sent at a really good
time, it was sent at about six o’clock, so I did their bath
and I remembered.
Which emollient is best?
Interviewees in study 2 said that they particularly valued
the section of the intervention that explained about the
different types of emollient available, helping them to
ﬁnd one of the right ‘thickness’.
Interviewer: And going back to the website, do you
remember which sections you used particularly?
Jo: It was the emollients one, about all the different emol-
lients, because we tried so many of them, that was the
main one that I used all the time, to ﬁnd a cream that he
liked, and that we hadn’t used before, and I ﬁnd some of
them are quite watery, and we wanted to ﬁnd one that
was quite, actually felt like it was doing something to his
skin, you know.
Although there was information about different emol-
lients on the website, some participants in study 2 felt
they would have liked even more, again suggesting the
importance of this topic to parents.
Table 2 Study 2 participant characteristics
Interviewee’s relationship to child 24 mothers 2 fathers
Interviewee’s age Median 37 years (range 24–44 years)
Age of most affected child Median 3 years (range 14 months–6 years)
Severity (parent asked if child’s
eczema
currently mild, moderate or severe)
16 mild 7 moderate 3 severe
Family structure Number of children in household median 2 (range 1–5); 25
households with both parents, 1 household with mother only
Interviewees’ employment status 5 full-time carers; 8 professional; 13 other such as admin or retail
Ethnicity 23 white British; 1 black or Asian British; 2 white non-British
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Interviewer: Is there anything you would have liked more
information on?
Petra: Well I suppose I would have liked a list of creams,
lotions, actual names of things. I think I did get a bit con-
fused, like I’ve got Dermol lotion, I’ve got Dermol cream,
well what’s the difference? Because you can go to the
doctor and they just prescribe something, but you don’t
really know—is it a cream, is it a lotion, is it a -? And I
only know that from the website. In a way it’s sort of
made me understand about the different products. I
should imagine for people who’ve got children with even
worse eczema, it’s quite bafﬂing, you know.
An unanticipated effect of the intervention was that it
prompted some parents to seek out different emollients.
Some had not realised that they could ask for a different
emollient, or that they were aware of this but did not
feel conﬁdent to reconsult just for this issue. Hayley said
she had not really appreciated that a different emollient
might be more beneﬁcial until she tried the ‘2-week
challenge’.
Interviewer: And did you do the two-week challenge at
all, do you remember?
Hayley: Yes, yes I did. That sort of highlighted that the
cream that he was having deﬁnitely wasn’t really effective;
in fact in some ways it seemed to sort of irritate him
more. It came up in more redness when he was using
that. So I went back to the doctor and swapped to
another cream and I found obviously that then doing the
two-week challenge on that cream, we found that one was
deﬁnitely a lot better for him.
DISCUSSION
This is the ﬁrst article we are aware of that focusses on
carers’ views about the use of leave-on emollients for
childhood eczema. We found that most carers of chil-
dren with eczema said that emollients helped their
child’s eczema in the short term, although they held
mixed views about the use of emollients in the long
term to prevent ﬂare-ups. Carers who had followed a
self-care support intervention expressed more positive
views towards using emollients to prevent ﬂare-ups.
Although these studies were not designed to test the
effectiveness of the self-care support intervention, it is
interesting that carers who had used it spoke about their
views and habits having changed due to information
that they had received. This suggests that reluctance to
use emollients in the long term may be overcome by
appropriate information and behaviour change support
(such as videos to model emollient use and prompts to
establish emollient use as ‘habit’).
A range of views and preferences were expressed
about ‘thickness’ of emollient, with an apparent trade-
off between perceived effectiveness of ‘thicker’ prepara-
tions against ease of application of ‘thinner’ prepara-
tions. There was widespread interest in obtaining more
information about different emollient products available
and the rationale for choosing one emollient prepar-
ation over another.
Findings in the context of existing research
Our ﬁndings echo previous descriptions of substantial
unmet information needs among carers of children with
eczema, particularly their wish for better information
about treatments.6 There is extensive literature on carers’
concerns about topical corticosteroids14–16 18 25 26 and
our study highlights that some carers also have concerns
around emollients. These ﬁndings highlight the need for
education or self-care support for carers of children with
eczema, although there is currently a scarcity of proven
interventions to support this.27 28
Our ﬁndings highlight the need for choice of emolli-
ent, as there were substantial differences in preferences
for different ‘thicknesses’, reﬂecting the mantra that,
‘The correct emollient is the one that the child will
use’.4 5 This choice is implemented as a ‘trial-and-error’
process of trying different emollients sequentially in
primary care, although this has previously been reported
as a frustrating process for some.8 21
Strengths and limitations
One strength of this study is that we used a population-
based sampling frame (as almost all UK residents are
registered with a GP) in order to seek a wide range of
views. However, our samples include relative few fathers,
ethnic minorities and low income or single parent
households and the response rate to participate in inter-
views was low.
The ﬁndings are strengthened by having been drawn
from two study groups with different experiences of
eczema education and support, highlighting that carers
who had received self-care support seemed happier to
use emollients in the long term. A limitation is that this
is a secondary analysis: if exploration of emollient use
had been our primary aim, we may have questioned par-
ticipants about this in greater depth and more fully
explored perceptions of emollients and how these
developed.
Implications for research
Questions remain about how the ‘trial-and-error’ process
can be shortened and made less frustrating for carers. It
has been suggested that a tray of different emollients
should be set up in clinic to enable carers to make a
choice about different emollients.29 In primary care,
where the majority of children with eczema are
managed, this may be difﬁcult to achieve in practice,
especially when trial-and-error learning in the home
setting is needed. Furthermore, there is no evidence at
present to show that the process of offering patients or
carers a range of emollients is beneﬁcial. Further evi-
dence is needed about how this process can be
improved and made less frustrating for carers.
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Implications for practice
Participants who had received more information about
eczema and explanation of rationale for emollient pre-
scribing appeared more convinced of the need for long-
term emollient use to prevent ﬂare-up. This reiterates
the importance of providing carers with clear accessible
information about eczema and an explanation of the
rationale behind continued use of emollient and choice
of emollient in promoting adherence. Interventions that
help promote emollient as a ‘habit’ could be particularly
effective, as could promotion of concepts such as a
‘2-week challenge’ of regular emollient use, which allows
carers to explicitly evaluate the outcomes of the emolli-
ent they are using. Providing such support or signpost-
ing carers towards more reliable sources of
evidence-based online resources is an essential part of
eczema management. (See box 4 for current online
resources for carers of children with eczema.)
CONCLUSIONS
Carers value having the choice of emollients and hold
varying views about which they ﬁnd most helpful.
However, the process of ‘trial and error’ can be frus-
trating and carers need a scientiﬁc rationale for
engaging in the process instead of feeling that it is
second rate ‘hit and miss’ clinical management. A
clear rationale for selection of speciﬁc emollients and
techniques for explicitly evaluating treatment out-
comes could help them feel more conﬁdent, involved
and empowered.
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